Investigating chemical tools to disrupt bacterial communication
Chemical probes to modulate acyl-homoserine lactone quorum signal synthesis
This study is looking at how a common bacteria called Pseudomonas aeruginosa talks to itself using special chemical signals, and it aims to find new ways to stop these signals so that the bacteria can't work together to cause infections, which could lead to better treatments for patients dealing with these infections.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boise State University NIH-funded |
| Lab location | 1 site (Boise, United States) |
| Project ID | NIH-10784999 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain bacteria, particularly Pseudomonas aeruginosa, communicate with each other using chemical signals called acyl-homoserine lactones (AHLs). By developing small molecule inhibitors that can block the synthesis of these signals, the research aims to interrupt the bacteria's ability to coordinate their behavior, which is crucial for their virulence. The study will explore various AHL analogs to identify how they can effectively inhibit the enzymes responsible for AHL production, potentially leading to new treatments for bacterial infections. Patients may benefit from this research as it could lead to novel therapies that reduce the severity of infections caused by these bacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by Gram-negative bacteria, particularly those caused by Pseudomonas aeruginosa.
Not a fit: Patients with infections caused by Gram-positive bacteria or those not affected by bacterial infections may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively combat bacterial infections by disrupting their communication systems.
How similar studies have performed: Other research has shown promise in using chemical probes to disrupt bacterial communication, indicating that this approach could be effective.
Where this research is happening
Boise, United States
- Boise State University — Boise, United States (Active)
Researchers
- Principal investigator: Nagarajan, Rajesh — Boise State University
- Study coordinator: Nagarajan, Rajesh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.